Alexandr Krajhanzl

Alexandr Krajhanzl has been a part of i&i Prague since September 2021. He is also a member of the Board for the Commercialization of Science and Research Results of Charles University Prague.

Between 1993 and 2004 he worked in various General Management functions in Cilag, later Janssen-Cilag, Johnson & Johnson. In 2004 as the Regional Director he became responsible for Business Development in EMEA Emerging Markets (80 countries) at Janssen, J&J Pharmaceutical companies. His responsibility changed from 2010 until 2017 when he acted as the Regional Director of New Business Development in the territory covering Europe Mid-Sized Markets. Between 2004 and 2017 he was a member of the Global BD team responsible for L&A and M&A initiatives and projects in Infectious Diseases and Vaccines. During his tenure in this position, he led or participated in numerous global, regional and local L&A and M&A deals. For his contribution, he was rewarded with two Global Standards of Leadership Awards of Johnson & Johnson.

Between 2013 and 2019 he also served as the President and Founding Member of Pharma Licensing Group Central and Eastern Europe and Vice-President of the European Pharma Licensing Board.

Alexandr completed his Master’s degree in Chemistry at Charles University in Prague. He has received a Ph.D. (CSc.) degree in Biochemistry and worked as a Charles University teacher for almost 11 years at the Department of Biochemistry, Faculty of Science.

Should you be interested in a collaboration in the field of drug development, Alexandr will be the right contact whom you can meet. He has been in the world of science and its commercialization for more than 20 years and has an extensive network of contacts among Pharma and Medical Device companies.